相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Risk-adapted BEACOPP regimen can reduce the cumulative dose of chemotherapy for standard and high-risk Hodgkin lymphoma with no impairment of outcome
Eldad J. Dann et al.
BLOOD (2007)
Long-term outcome of Hodgkin disease patients following high-dose busulfan, etoposide, cyclophosphamide, and autologous stem cell transplantation
Navin Wadehra et al.
BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION (2006)
Outpatient fractionated ifosfamide, carboplatin and etoposide as salvage therapy in relapsed and refractory non-Hodgkin's and Hodgkin's lymphoma
M. S. Hertzberg et al.
ANNALS OF ONCOLOGY (2006)
Survival in Hodgkin's disease patients - Report of 25 years of experience at the Milan Cancer Institute
G Bonadonna et al.
EUROPEAN JOURNAL OF CANCER (2005)
Prognostic factors affecting long-term outcome after stem cell transplantation in Hodgkin's lymphoma autografted after a first relapse
A Sureda et al.
ANNALS OF ONCOLOGY (2005)
Second primary breast cancer after Hodgkin's disease
A Horwich et al.
BRITISH JOURNAL OF CANCER (2004)
Outcome and prognostic factors in advanced Hodgkin's disease treated with high-dose chemotherapy and autologous stem cell transplantation: a study of 341 patients
J Czyz et al.
ANNALS OF ONCOLOGY (2004)
The value of augmented preparative regimens combined with an autologous bone marrow transplant for the management of relapsed or refractory Hodgkin disease: A Southwest Oncology Group Phase II Trial
PJ Stiff et al.
BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION (2003)
Aggressive conventional chemotherapy compared with high-dose chemotherapy with autologous haemopoietic stem-cell transplantation for relapsed chemosensitive Hodgkin's disease:: a randomised trial
N Schmitz et al.
LANCET (2002)
分享论文
